BiotechTube
Pharmsynthez

Pharmsynthez

Saint Petersburg, Europe - Other· Est.
en.pharmsynthez.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17M

Overview

Pharmsynthez is a private, integrated Russian pharmaceutical company with a research and production facility operational since 2001. Its core strategy combines the development of innovative drug delivery platforms and small molecule therapeutics with the commercial production and sale of APIs and finished medicines, primarily within CIS markets. The company engages in international B2B partnerships for chemical compounds while also marketing its own branded products, positioning itself as a hybrid developer and manufacturer.

Drug DeliverySmall Molecules

Technology Platform

Focus on developing organ-specific drug delivery technologies and innovative methods for API manufacture.

Funding History

3
Total raised:$17M
Grant$5M
Series A$10M
Seed$2M

Opportunities

The growing global market for advanced drug delivery systems presents a major opportunity to license its platform technologies or develop proprietary improved formulations.
Its established API manufacturing capabilities position it well to secure more contracts from Western companies seeking reliable, cost-effective chemical synthesis partners.

Risk Factors

Significant geopolitical and sanctions-related risk due to its Russian base, which could disrupt supply chains and international partnerships.
High R&D risk associated with developing novel drug delivery systems in a competitive landscape, with no disclosed clinical-stage assets.

Competitive Landscape

In drug delivery, it competes with global biotech platforms and large pharma internal groups. As an API manufacturer, it competes on cost and quality with other Russian, Indian, and Chinese CDMOs. Its commercial medicines face competition from local generics producers and multinationals in CIS markets.

More companies in Europe - Other →